Physiology AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


News Physiol Sci 19: 44-50, 2004; doi:10.1152/nips.01457.2003
1548-9213/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landsberg, J. W.
Right arrow Articles by Yuan, J. X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landsberg, J. W.
Right arrow Articles by Yuan, J. X.-J.
News in Physiological Sciences, Vol. 19, No. 2, 44-50, April 2004
© 2004 Int. Union Physiol. Sci./Am. Physiol. Soc.

Calcium and TRP Channels in Pulmonary Vascular Smooth Muscle Cell Proliferation

Judd W. Landsberg and Jason X.-J. Yuan

Department of Medicine, School of Medicine, University of California, San Diego, California 92103

    Abstract
 
Ca2+ is a major trigger for pulmonary vasoconstriction and a stimulus for pulmonary vascular smooth muscle cell proliferation. The transient receptor potential cation channels participate in regulating intracellular Ca2+ and thus vascular contractility and cell proliferation. Upregulation of genes encoding these channels is involved in the development of pulmonary hypertension.


    Introduction
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Pulmonary hypertension is mediated to a large extent by plexogenic pulmonary arteriopathy. The dominant features of this arteriopathy include 1) sustained pulmonary vasoconstriction, 2) pulmonary arterial medial hypertrophy and muscularization of distal vessels due to smooth muscle cell hyperplasia and hypertrophy, and 3) obliterative intimal lesions in which smooth muscle cells predominate. Therefore, identifying the factors involved in triggering pulmonary vasoconstriction and promoting pulmonary artery smooth muscle cell (PASMC) proliferation is an area of active investigation. Pulmonary vascular tone and PASMC proliferation are both regulated by intracellular Ca2+ (6, 12, 14, 17, 20). An increase in cytoplasmic free Ca2+ concentration ([Ca2+]cyt) in PASMC induces both contraction and proliferation, thereby uniting the two fundamental derangements (pulmonary vasoconstriction and vascular medial hypertrophy) underlying severe pulmonary hypertension.

Vasoactive and mitogenic agonists trigger Ca2+ mobilization by activating inositol 1,4,5-trisphosphate (IP3) receptors in the sarcoplasmic reticulum (SR) membrane, leading to SR Ca2+ release and subsequent depletion. This internal Ca2+ store depletion triggers a sustained Ca2+ influx known as capacitative Ca2+ entry (CCE). The two major functions of CCE are to refill the SR Ca2+ stores and to maintain adequate Ca2+ levels in the cytosol and nucleus in the face of high levels of mitogenic stimulation. The Ca2+ elevation associated with CCE occurs via activity of a special family of Ca2+ channels known as the store-operated Ca2+ channels (SOCs). These channels consist of hetero- or homotetrameric subunits encoded by the transient receptor potential (TRP) genes (19). Expression of TRP genes, function of SOCs, and amplitude of CCE are all involved in the regulation of pulmonary vascular tone and PASMC growth under physiological conditions (6, 17, 20). Furthermore, in PASMC isolated from patients with primary pulmonary hypertension (PPH), CCE is enhanced and TRP genes are upregulated, suggesting that increased expression of the SOC responsible for CCE may play an important role in the pathophysiology of PPH (6). This review focuses on the role of Ca2+ in PASMC proliferation, highlighting the importance of CCE, mediated by SOC and TRP gene expression, in maintaining the adequate intracellular Ca2+ required to stimulate and maintain proliferation.


    Role of Ca2+ in cell proliferation
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Intracellular Ca2+ is a critical second messenger responsible for linking external stimuli to contraction, proliferation, and gene expression. Mitogenic stimulation leads to a rise in [Ca2+]cyt due to Ca2+ release from internal stores and Ca2+ influx through sarcolemmal Ca2+ channels. A rise in [Ca2+]cyt is transmitted by passive diffusion through nuclear pores in the nuclear envelope, thus increasing nuclear Ca2+ concentration ([Ca2+]n) (8). Both elevated [Ca2+]cyt and [Ca2+]n, via an active Ca2+-calmodulin (CaM) complex, promote cell proliferation by stimulating quiescent cells to enter the cell cycle, as well as by driving proliferating cells through the cell cycle and mitosis. The activated Ca2+-CaM complex activates specific Ca2+-CaM-dependent kinases (e.g., CaM kinase IV) that promote phosphorylation of proteins, such as Ca2+/cAMP response element (CRE) binding protein (CREB, a nuclear Ca2+-responsive transcription factor) and Ras (a cytosolic Ca2+-responsive transcription factor), that are required for initiating and maintaining the cell cycle. In the cell cycle, the transition from G0 to G1 phase (i.e., from the resting state to the initiation of DNA synthesis), transition from G1 to S phase (i.e., to the replication of nuclear DNA), and transition from G2 to M (mitosis) phase as well as the entire mitosis phase are dependent on the activated Ca2+-CaM complex (1).

Beyond signal transduction, an adequate level of Ca2+ in intracellular stores, such as the SR, is crucial for normal cellular functions, including posttranslational modifications (e.g., correct folding, assembly, and glycosylation) of recombinant proteins. Therefore, maintenance of a high Ca2+ concentration in the SR ([Ca2+]SR) also plays a critical role in optimizing protein and lipid synthesis and sorting. When the SR Ca2+ is depleted, the resultant disturbance of posttranslational modification of proteins may result in problematic protein trafficking, SR stress (3), growth arrest (15), and apoptosis (9). Indeed, removal of external Ca2+ and/or depletion of stored Ca2+ have been shown to induce growth arrest in vascular smooth muscle cells (6, 15).


    Role of Ca2+ in gene expression and cell growth
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Elevated intracellular Ca2+, including a rise in [Ca2+]cyt and/or in [Ca2+]n, is the second messenger responsible for linking external mitogenic stimulus to gene expression in vascular smooth muscle cells. Expression of the immediate early genes that encode transcription factors like c-Fos and c-Jun, and of cell cycle regulators like cyclin A and E, can be stimulated by intracellular Ca2+ because the promoters of these genes contain the CRE (7, 8, 18). There are many Ca2+-sensitive transcription factors (e.g., c-Fos/c-Jun, Ras, cyclin A/B, CREB, proline-rich tyrosine kinase 2, NF-{kappa}B) and signal transduction proteins (e.g., CREB kinase, CaM kinase IV, MAPK-activated protein kinase 2) that are involved in cell growth and proliferation (7, 8).

The magnitude, duration, and frequency of agonist- or mitogen-mediated rises in [Ca2+]cyt and [Ca2+]n determine what kinds of Ca2+-regulated genes are activated. A well-characterized Ca2+-activated gene is the c-fos gene; its promoter includes two elements that mediate the effect of Ca2+: 1) the serum response element that binds serum response factor and ternary complex factor, and 2) the CRE that binds the CREB. Induction of c-fos is a critical early event in cell growth. Expression of c-fos and c-jun proto-oncogenes is regulated by a sustained increase in [Ca2+]cyt due to Ca2+ influx. A rise in [Ca2+]cyt activates c-fos transcription via serum response element, whereas a rise in [Ca2+]n activates c-fos transcription via CRE (7, 8). The differential activation of the c-fos promoter by the spatially distinct pools of Ca2+ indicates that local fluctuations of Ca2+ concentration may result in different transcriptional responses. Further studies indicate that the amplitude, duration, frequency, and spatial properties of the Ca2+ signals carried via distinct sarcolemmal Ca2+ channels (e.g., voltage-gated, receptor-operated, or store-operated) differ significantly. For example, Ca2+ influx through L-type voltage-gated Ca2+ channels efficiently activates CRE-dependent gene expression, but Ca2+ influx through N-methyl-D-aspartate (NMDA) receptors does not. An intriguing possibility is that the different Ca2+ channels associate preferentially with their specific Ca2+-activated effector molecules (2, 4, 5, 7, 8, 11), allowing this ubiquitous second messenger to have characteristic downstream effects.


    Regulation of [Ca2+]cyt in PASMC
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
In vascular smooth muscle cells, including PASMC, [Ca2+]cyt can be increased by Ca2+ influx through sarcolemmal Ca2+ channels and by Ca2+ release from intracellular stores (mainly the SR). Both extracellular Ca2+ and intracellularly stored Ca2+ in the SR are significantly higher (5,000–20,000 times) than [Ca2+]cyt. This enormous concentration gradient allows Ca2+ influx and release to occur without additional energy expenditure. [Ca2+]cyt can be decreased by Ca2+ extrusion via the sarcolemmal Ca2+-Mg2+-ATPase and Na+/Ca2+ exchanger and by Ca2+ sequestration into the SR via the Ca2+-Mg2+-ATPase on the SR membrane (SERCA). In other words, cytoplasmic Ca2+ homeostasis is achieved by balancing the mechanisms that increase [Ca2+]cyt (e.g., Ca2+ influx and release) with the mechanisms that decrease [Ca2+]cyt (e.g., Ca2+ extrusion and sequestration) (Fig. 1Go).



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 1. Proposed mechanisms involved in the regulation of Ca2+ homeostasis in pulmonary artery smooth muscle cells (PASMC). Mitogenic agonists or growth factors bind to receptors, triggering the formation of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). a: DAG activates receptor-operated channel (ROC)-mediated Ca2+ influx. b: IP3 activates IP3 receptor (IP3R)-mediated Ca2+ release. c: Subsequent depletion of Ca2+ from the sarcoplasmic reticulum (SR) in turn activates store-operated channel (SOC)-mediated Ca2+ influx. d: Membrane depolarization (e.g., by inhibition of Kv channel activity) leads to voltage-dependent Ca2+ channel (VDCC)-mediated Ca2+ influx. e: A high level of local cytoplasmic Ca2+ concentration ([Ca2+]cyt) is capable of triggering ryanodine receptor (RyR)-mediated Ca2+ release, a positive feedback mechanism known as Ca2+-induced Ca2+ release (CICR). The low [Ca2+]cyt under resting conditions is achieved and maintained mainly by active Ca2+ sequestration into the sarcoplasmic reticulum (SR) by the Ca2+-Mg2+-ATPase in the SR (SERCA) and Ca2+ extrusion by the Ca2+-Mg2+-ATPase in the plasma membrane.

 
In PASMC, increased [Ca2+]cyt may occur by 1) activation of receptor-operated (or ligand-gated) Ca2+ channels (ROCs) that are opened, independent of membrane potential, by agonist-mediated activation of membrane receptors; 2) activation of SOCs that are opened, independent of membrane potential, by depletion of Ca2+ from intracellular stores; 3) activation of voltage-dependent Ca2+ channels (VDCC) that are opened by membrane depolarization; 4) activation IP3 receptor-mediated Ca2+ release from the IP3-sensitive SR; and 5) activation of ryanodine receptor-mediated Ca2+ release from ryanodine-sensitive SR (Fig. 1Go).

Regulation of [Ca2+]n is a matter of some debate and likely varies widely depending on cell type (8). In vascular smooth muscle cells, elevated [Ca2+]cyt leads rapidly to elevated [Ca2+]n by passive diffusion through nuclear pores. The nuclear pore protein has been shown to contain Ca2+ binding sites allowing conformational and, presumably, permeability change to occur on the basis of Ca2+ concentration (7, 8).


    CCE in PASMC
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Depletion of Ca2+ from the SR triggers CCE. The SR Ca2+ store depletion can be achieved actively (by activating IP3 receptors) or passively (by inhibiting SERCA). Exposure of PASMC to a mitogenic agonist in the absence of external Ca2+ increases IP3 production, activates the IP3 receptor, and ultimately depletes SR Ca2+ by inducing Ca2+ release. Passive store depletion occurs when SERCA is inhibited [e.g., by cyclopiazonic acid (CPA) or thapsigargin] and Ca2+ leaks out of the SR down a steep chemical or concentration gradient.

Figure 2Go illustrates an example of how CCE is induced in PASMC by passive and active depletion of Ca2+ from the SR. As shown in Fig. 2AGo, CCE in PASMC can be observed as a rise in [Ca2+]cyt occurring after passive store depletion with CPA. In the absence of extracellular Ca2+ (Fig. 2AaGo), CPA, by blocking Ca2+ sequestration into the SR, induces a transient rise in [Ca2+]cyt due to leakage of Ca2+ from the SR to the cytoplasm (Fig. 2AbGo). The CPA-induced [Ca2+]cyt transient declines back to the original baseline level after 5–7 min as the SR Ca2+ is depleted (Fig. 2AcGo). Under these conditions, restoration of extracellular Ca2+ induces a further rise in [Ca2+]cyt due to CCE (Fig. 2AdGo), which is inhibited reversibly by the SOC blockers Ni2+ (Fig. 2AeGo) and SKF-96365 (Fig. 2AgGo). Removal of CPA from extracellular solution promotes cytosolic Ca2+ into the SR and reduces [Ca2+]cyt (Fig. 2AhGo).



View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 2. A: schematic diagram and a representative record (tracing, middle) of [Ca2+]cyt change in PASMC showing the cellular events involved in capacitative Ca2+ entry (CCE) triggered by passive store depletion. When the cell is superfused with Ca2+-free solution (0Ca), [Ca2+]cyt is maintained at a very low level and the SR Ca2+ concentration ([Ca2+]SR) is very high due to an active Ca2+ uptake into the SR by SERCA (a). Application of cyclopiazonic acid (CPA) blocks SERCA and induces a transient rise in [Ca2+]cyt due to passive Ca2+ leakage from the SR to the cytosol according to its concentration gradient (b). The passive leakage soon (5–10 min) leads to store depletion and opening of SOC (c). Restoration of extracellular Ca2+ then results in a large increase in [Ca2+]cyt due to CCE (d). Functional blockade of SOC with Ni2+ (e) and SKF-96365 (SK, g) reversibly inhibits the CCE-induced increase in [Ca2+]cyt (f). Washout of extracellular CPA restores the function of SERCA and restores the intracellular Ca2+ milieu of a low [Ca2+]cyt and high [Ca2+]SR (h). B: CCE induces a contraction in isolated rat pulmonary artery (PA) rings triggered by active store depletion. In the absence of external Ca2+, the {alpha}-adrenergic receptor agonist phenylephrine (PE, 10 µM) causes a transient contraction via IP3-mediated Ca2+ release, which is spontaneously terminated when internal stores are depleted. Restoration of extracellular Ca2+, despite the presence of the {alpha}-receptor blocker phentolamine (Phen, 1 µM) and the VDCC blocker verapamil (Vp, 0.5 µM), gives rise to a sustained contraction due to CCE triggered by PE-induced active store depletion. C: whole cell SOC currents (ISOC) in PASMC induced by passive and active store depletion in PASMC. Cells were superfused with solutions containing 120 mM Na+ and 20 mM Ca2+ as charge carrier and were dialyzed with solutions containing 138 mM Cs+ (to eliminate K+ currents) and ~100 nM free Ca2+. The holding potential was set at 0 mV to inactivate voltage-gated cation (e.g., Na+ and Ca2+) and anion (e.g., Cl-) channels. Whole cell currents were elicited by 300-ms voltage steps from -120 to 0 mV before and after 15-min application of CPA (a) or PE (b) in the absence (CPA or PE) or presence (CPA+Ni or PE+La) of SOC blockers Ni2+ or La3+.

 
Active store depletion by agonist-mediated production of IP3 and release of Ca2+ from the SR through IP3 receptors also triggers CCE. Figure 2BGo shows an example of how CCE can be induced by active store depletion and how CCE contributes to agonist-mediated vasoconstriction in an isolated rat pulmonary artery ring. In the absence of external Ca2+, PA rings exposed to the {alpha}-adrenergic receptor agonist phenylephrine (PE) demonstrate a short (4–6 min) and transient contraction, due presumably to IP3-mediated Ca2+ release. The contraction induced by Ca2+ release is spontaneously terminated when intracellular stores are depleted and cytosolic Ca2+ is extruded. Under these conditions, application of the {alpha}-receptor blocker phentolamine (Phen, 1 µM) and the VDCC blocker verapamil (Vp, 0.5 µM) closes both ROCs (indirectly by interfering with the receptor) and VDCC. Restoration of extracellular Ca2+ in the presence of Phen and Vp gives rise to a sustained contraction due to CCE. In this experiment, CCE is triggered by PE-induced active store depletion (Fig. 2BGo). The CCE-mediated contraction is sensitive to Ni2+ and La3+ but is not sensitive to Vp and nifedipine, highlighting its dependence on SOC activity (12).
"...increase in [Ca2+]cyt due to CCE is a critical signal transduction element ...."

Activity of SOCs is the major determinant of the amplitude of CCE, which, in turn, governs the magnitude of CCE-mediated contraction. The cation currents through store depletion-activated SOCs can be recorded by using patch clamp techniques in single PASMC (Fig. 2CGo). To record SOC currents (ISOC) elicited by passive SR Ca2+ depletion, the cells are first superfused with solutions containing 120 Na+ and 20 mM Ca2+ and dialyzed with solutions containing 138 mM Cs+ (to eliminate K+ currents) and ~100 nM free Ca2+. The holding potential is set at 0 mV to inactivate voltage-gated cation (Na+ and Ca2+) and anion (Cl-) channels. Whole cell currents are elicited by 300-ms voltage steps from -120 to 0 mV before and after application of CPA (Fig. 2CaGo) or PE (Fig. 2CbGo), which either passively or actively depletes Ca2+ from the SR within 10 min (see Fig. 2, A and BGo). Subtraction of the current recorded under control conditions from the current recorded during application of CPA or PE reveals that ISOC is activated by either active or passive depletion of Ca2+ (Fig. 2CGo). Blockade of SOC with Ni2+ or La3+ reversibly reduces the amplitudes of ISOC (Fig. 2CGo) and CCE (Fig. 2AGo) (6) and significantly inhibits CCE-mediated pulmonary vasoconstriction (12) and PASMC proliferation (6, 17, 20).

Together, these observations indicate that CCE can be induced by both active and passive depletion of stored Ca2+ in the SR. The increase in [Ca2+]cyt due to CCE is a critical signal transduction element involved in smooth muscle contraction and PASMC proliferation.


    CCE is enhanced in PASMC during proliferation
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Removal or chelation of extracellular Ca2+ inhibits PASMC growth in the presence of serum and growth factors (6, 15), suggesting that a constant Ca2+ influx is required for PASMC proliferation. Passive depletion of SR Ca2+ stores with CPA or thapsigargin further inhibits PASMC growth (6, 12, 15, 17, 20). The synergistically inhibitory effects of chelation of extracellular Ca2+ and depletion of stored Ca2+ in the SR on PASMC growth highlight the importance of both Ca2+ influx and adequate internal Ca2+ stores in PASMC proliferation.

When PASMC are growth arrested by incubation in a serum-free and growth factor-free medium, both the basal level of resting [Ca2+]cyt (Fig. 3, A and BaGo) and CPA-mediated CCE amplitude (Fig. 3, A and BbGo) are much lower than in proliferating cells cultured in a medium containing 5% fetal bovine serum and growth factors. The rise in [Ca2+]cyt due to CPA-mediated CCE is approximately threefold greater in proliferating PASMC than in growth-arrested cells and is insensitive to VDCC blockers and sensitive to the SOC blockers Ni2+ and SKF-96365 (see Fig. 2AGo) (6). Furthermore, the CPA-mediated transient increase in [Ca2+]cyt in the absence of extracellular Ca2+ (which is mainly due to Ca2+ leakage from the SR to the cytoplasm, and its amplitude partially reflects [Ca2+]SR) is approximately twofold greater in proliferating cells than in growth-arrested (or quiescent) PASMC. This indicates that Ca2+ concentration in the SR is also increased in proliferating PASMC (Fig. 3CGo). In addition to the fluorescence microscopy results, electrophysiological data also show that ISOC, induced by passive store depletion with CPA, is significantly increased in proliferating PASMC compared with growth-arrested cells (6).



View larger version (46K):
[in this window]
[in a new window]
 
FIGURE 3. Resting [Ca2+]cyt and CCE are enhanced in PASMC during proliferation. A: representative records showing the changes in [Ca2+]cyt before, during, and after extracellular application of CPA in growth-arrested (left) and proliferating (right) PASMC. B: pseudocolor images showing the changes of [Ca2+]cyt in growth-arrested (ad) and proliferating (a’–d’) PASMC in response to CPA (5 µM) in the absence and presence of extracellular Ca2+. Fura-2 fluorescence (F360) images show PASMC from which [Ca2+]cyt were measured (left). C: summarized data (means ± SE) showing the resting [Ca2+]cyt (left), the amplitude of CPA-mediated Ca2+ mobilization (middle), and the amplitude of CCE (right) in growth-arrested (blue bars) and proliferating (red bars) PASMC. **P < 0.01, *P < 0.05 vs. blue bars. Figure modified from Ref. 6, with permission.

 
Together, these data suggest that mitogen-induced PASMC proliferation requires elevated Ca2+ concentrations in the cytoplasm, nucleus, and SR. To maintain adequate intracellular Ca2+ concentration in the face of high levels of mitogenic stimulation, PASMC increase SOC activity, leading to enhanced CCE. Blockade of SOC with Ni2+, La2+, or SKF-96365 or downregulation of genes that encode SOC with antisense oligonucleotides inhibits CCE, reduces [Ca2+]cyt and [Ca2+]SR, and attenuates PASMC proliferation (6, 17, 20).

The mechanism behind the enhanced CCE seen in proliferating PASMC likely involves upregulation of the genes responsible for encoding SOC (e.g., TRP genes). Exposure of PASMC to growth factors or mitogenic agonists activates tyrosine kinase-coupled receptors (e.g., PDGF receptor). The subsequent phosphorylation and activation of signal transduction proteins (e.g., protein kinases) and transcription factors (e.g.,signal transducer and activator of transcription, c-Jun) lead to upregulated TRP gene expression, increased SOC number, and, ultimately, enhanced CCE (Fig. 4Go) (20).



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 4. Schematic diagram depicting the role of upregulated canonical transient receptor potential family (TRPC) transcription and enhanced CCE in promoting PASMC proliferation. Activation of receptors by mitogenic stimulation leads to IP3 formation and subsequent IP3-mediated Ca2+ release. Repeated or constant mitogenic stimulation and Ca2+ release lead to store depletion, which in turn activates SOCs and triggers CCE. Ligand-receptor binding also mediates opening of ROCs via DAG and increases Ca2+ influx via ROCs. Upregulation of TRPC channel expression increases the number of SOCs and/or ROCs in the plasma membrane and enhances agonist-mediated Ca2+ influx via CCE and/or receptor-mediated Ca2+ entry. The subsequent increases in [Ca2+]cyt and nuclear Ca2+ concentration ([Ca2+]n) may promote PASMC proliferation by activating cytoplasmic signal transduction proteins [e.g., Ca2+/cAMP response element (CRE) binding protein (CREB) and mitogen-activated protein kinase] and transcription factors (e.g., c-Fos and c-Jun) and by moving quiescent cells into the cell cycle and propelling the proliferating cell through mitosis. In addition, a rise in [Ca2+]cyt and activation of STAT3 (e.g., via Ca2+-independent mechanism) may further enhance TRPC expression by upregulating c-Jun.

 

    The molecular identity of SOC in PASMC
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
The molecular identity of SOC has not been completely elucidated. Work in this area has focused on TRP gene-encoded proteins on the basis of observations that expression of TRP genes in a heterologous transfection system leads to the formation of Ca2+-permeable channels activated by receptor activation and store depletion (19). Each TRP-encoded subunit contains six transmembrane domains (S1–S6) with a pore-forming loop between S5 and S6. Both NH2 and COOH terminals are located intracellularly (19).

The mammalian TRP family can be divided into three subfamilies: 1) TRP-canonical (TRPC) family (or short TRP channels), which is comprised of seven members, TRPC1–7; 2) TRP-vanilloid (TRPV) family (or Osm-9-like TRP channels), which consists of six members, TRPV1–6; and 3) TRP-melastatin (TRPM) family (or long TRP chanels), which contains eight members, TRPM1–8. There are three or more ankyrin domains in the NH2-terminal cytosolic region of the short (TRPC) and Osm-9-like (TRPV) TRP channels and a proline-rich motif in the cytosolic COOH-terminal region in the vicinity of S6 of the short and long (TRPM) TRP channels. It has been shown that native SOCs are mainly heterotetramers comprised of different TRP isoforms. Sensitivity to store depletion may be mediated by the cytosolic COOH-terminal tail connected to the S6 transmembrane domain, but the mechanism linking store depletion to SOC activation is still unclear (19). The greatest homology between the subfamilies is seen in the S6 transmembrane domain, and the greatest variance is found in the COOH terminus. The subfamily members differ in their distribution throughout the body as well as in their mode of regulation.

Several human TRP homologs have been identified, including TRPC1, TRPC3, TRPC4, and TRPC6 in human lung tissues and pulmonary vascular smooth muscle and endothelial cells. The human TRP proteins likely encode ROCs as well as SOCs. Data from different cell types as well as experiments involving overexpression of specific TRP proteins have yielded conflicting results in attempting to correlate specific TRP isoforms with SOC properties. This may be explained by the heterotetrameric structure of the TRP channels. For example, a channel made up of two TRPC1, a TRPC3, and a TRPC6 protein may form a functional SOC activated by store depletion, whereas a channel made of two TRPC3 and two TRPC6 proteins may form a functional ROC activated predominantly by receptor-activated G proteins or diacylglycerol. By examining the gating property of overexpressed mammalian TRPC channels, numerous reports demonstrate that TRPC1, TRPC2, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7 are activated in response to store depletion with SERCA inhibitors (e.g., thapsigargin, CPA) or ionophores (e.g., ionomycin). However, equally numerous reports indicate that TRPC channels overexpressed in mammalian cells are activated by PLC-coupled receptors and are not activated by store depletion (19). Therefore, the functional link between specific TRP gene products and agonist-mediated Ca2+ entry (e.g., CCE or receptor-mediated Ca2+ entry) remains an area for further study.


    Upregulated TRPC expression in human PASMC during proliferation
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Human TRPC1 is widely distributed throughout the body, whereas TRPC6 is highly expressed in lung tissues and pulmonary arteries. Overexpression of TRPC6 in mammalian cells has been shown to enhance agonist-induced Ca2+ entry (10). Inhibition of TRPC6 expression with antisense oligonucleotides has been shown to inhibit agonist-mediated vascular tone in some experimental models (16). In proliferating human PASMC, TRPC1 and TRPC6 mRNA and protein expression are upregulated and the amplitude of ISOC and CCE (induced by passive store depletion) are both enhanced. The increased mRNA expression of TRPC1 precedes the increase in cell number. Inhibition of either TRPC1 or TRPC6 gene expression with antisense oligonucleotides decreases CCE and attenuates PASMC proliferation (6, 17, 20). These data suggest that TRPC1 and TRPC6 may be involved in forming native SOCs responsible for CCE in human PASMC and, furthermore, that enhanced TRPC expression and CCE are a prerequisite for human PASMC proliferation.

In attempts to understand the mechanisms involved in the enhanced TRPC gene expression, ISOC, and CCE seen in proliferating PASMC, we examined the role of STAT3 and c-Jun in rat PASMC proliferation (20). The tyrosine-phosphorylated STAT3 is a downstream signal transduction protein that is activated, via phosphorylation, upon ligand binding to the PDGF receptor. c-Jun is a transcription factor that stimulates gene expression and promotes cell growth. Treatment of PASMC with PDGF induces a transient increase (within 30–60 min) in protein levels of phosphorylated STAT3 (20), which is followed by a sustained increase (up to 48 h) in protein expression of c-Jun. Inhibition of c-Jun expression with specific antisense oligonucleotides prevents PDGF-induced upregulation of TRPC6, ISOC, CCE, and proliferation (as measured by [3H]thymidine uptake). Overexpression of c-jun enhances TRPC6 protein expression in PASMC. These data suggest that growth factor-mediated TRPC upregulation may involve Ca2+-CaM-dependent kinase-mediated phosphorylation of STAT3 and upregulation of c-Jun (Fig. 4Go) (20).


    Upregulated TRPC expression and enhanced CCE in PASMC contribute to the development of PPH
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
As well as its essential role in normal PASMC proliferation, increased CCE, secondary to increased formation of SOCs by upregulated TRP genes, may be important in the development of pulmonary vascular remodeling in patients with PPH. Using PASMC isolated from patients undergoing lung transplant for PPH and secondary pulmonary hypertension (SPH), our laboratory has been able to compare the magnitude of CCE between PPH-PASMC and SPH-PASMC. When matched for pulmonary arterial pressure and pulmonary vascular resistance, growth-arrested PASMC from PPH patients demonstrate significantly higher resting [Ca2+]cyt compared with cells from SPH patients. In addition, the magnitude of CCE, evoked by passive store depletion with CPA, is significantly greater in PASMC from PPH patients than in cells from SPH patients (6). At a molecular level, PPH is a heterogeneous disorder, with abnormal PASMC proliferation as its central theme. These data suggest that enhanced CCE, secondary to upregulated TRP genes, may be important in the pathogenesis of vascular remodeling in severe pulmonary hypertension and/or PPH. Accordingly, interruption of CCE at any point, from agents that downregulate TRPC gene expression to specific blockers for SOCs in PASMC, may prove beneficial in the development of therapeutic approaches for treatment of severe pulmonary hypertension.


    Summary
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 
Elevated [Ca2+]cyt is an important stimulus driving PASMC proliferation under both physiological and pathological conditions. By binding CaM, elevated cytoplasmic Ca2+ leads to the formation of the activated Ca2+-CaM complex. This complex is capable of activating several CaM kinases involved in the phosphorylation of signal transduction proteins and transcription factors responsible for promoting gene transcription and stimulating the PASMC to go through the cell cycle.

Mitogenic agonists stimulate PASMC growth by elevating [Ca2+]cyt via Ca2+ influx and release. During PASMC proliferation, the essential resource of elevated [Ca2+]cyt and [Ca2+]n needs to be maintained by 1) increasing the number of functional Ca2+ channels in the plasma membrane, 2) enhancing the function of existing Ca2+ channels, and 3) maintaining the signal transduction between emptied SR and the plasmalemmal permeability to Ca2+. The TRPC family is a unique group of cation channels that are opened by both receptor activation and store depletion. Upregulation and functional enhancement of these channels have been implicated in both normal PASMC proliferation and in pulmonary vascular medial hypertrophy in patients with pulmonary arterial hypertension. Better defining the events involved in TRPC gene expression, SOC activation, and CCE regulation could lead to the development of new therapeutic approaches for abnormal PASMC proliferation in patients with severe pulmonary hypertension.


    Acknowledgments
 
This work was supported in part by grants from the National Heart, Lung, and Blood Institute (HL-64945, HL-54043, HL-66012, HL-69758, and HL-66941).


    References
 Top
 Introduction
 Role of Ca2+ in...
 Role of Ca2+ in...
 Regulation of [Ca2+]cyt in...
 CCE in PASMC
 CCE is enhanced in...
 The molecular identity of...
 Upregulated TRPC expression in...
 Upregulated TRPC expression and...
 Summary
 References
 

  1. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 361: 315–325, 1993.[CrossRef][Medline]
  2. Cruzalegui FH, Hardingham GE, and Bading H. c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation. EMBO J 18: 1335–1344, 1999.[CrossRef][ISI][Medline]
  3. Cudna RE and Dickson AJ. Endoplasmic reticulum signaling as a determinant of recombinant protein expression. Biotechnol Bioeng 81: 56–65, 2003.[CrossRef][ISI][Medline]
  4. Deisseroth K, Heist EK, and Tsien RW. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392: 198–202, 1998.[CrossRef][Medline]
  5. Dolmetsch RE, Lewis RS, Goodnow CC, and Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386: 855–858, 1997.[CrossRef][Medline]
  6. Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, Rubin LJ, and Yuan JXJ. Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280: H746–H755, 2001.[Abstract/Free Full Text]
  7. Hardingham GE, Chawla S, Johnson CM, and Bading H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385: 260–265, 1997.[CrossRef][Medline]
  8. Hardingham GE, Cruzalegui FH, Chawla S, and Bading H. Mechanisms controlling gene expression by nuclear calcium signals. Cell Calcium 23: 131–134, 1998.[CrossRef][ISI][Medline]
  9. He H, Lam M, McCormick TS, and Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 138: 1219–1228, 1997.[Abstract/Free Full Text]
  10. Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, Ito Y, and Mori Y. The transient receptor potential protein homologue trp6 is the essential component of vascular {alpha}1-adrenoreceptor-activated Ca2+-permeable cation channel. Circ Res 88: 325–332, 2001.[Abstract/Free Full Text]
  11. Johnson CM, Hill CS, Chawla S, Treisman T, and Bading H. Calcium controls gene expression via three distinct pathways that can function independently of the Ras/mitogen-activated protein kinases (ERKs) signalling cascade. J Neurosci 17: 6189–6202, 1997.[Abstract/Free Full Text]
  12. McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, and Yuan JX. Capacitative Ca2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280: L870–L880, 2001.[Abstract/Free Full Text]
  13. Parekh AB, Fleig A, and Penner R. The store-operated calcium current ICRAC: nonlinear activation by InsP3 and dissociation from calcium release. Cell 89: 973–980, 1997.[CrossRef][ISI][Medline]
  14. Pitt BR, Weng W, Steve AR, Blakely RD, Reynolds I, and Davies P. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol Lung Cell Mol Physiol 266: L178–L186, 1994.[Abstract/Free Full Text]
  15. Short AD, Bian J, Ghosh TK, Waldron RT, Rybak SL, and Gill DL. Intracellular Ca2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 90: 4986–4990, 1993.[Abstract/Free Full Text]
  16. Slish DF, Welsh DG, and Brayden JE. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol 283: H2196–H2201, 2002.[Abstract/Free Full Text]
  17. Sweeney M, Yu Y, Platoshyn O, Zhang S, McDaniel SS, and Yuan JX. Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L144–L155, 2002.[Abstract/Free Full Text]
  18. Sylvester AM, Chen D, Krasinski K, and Andres V. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest 101: 940–948, 1998.[ISI][Medline]
  19. Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, and Gill DL. The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4: E263–E272, 2002.[CrossRef][ISI][Medline]
  20. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, and Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316–C330, 2003.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Berra-Romani, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina
Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture
Am J Physiol Cell Physiol, September 1, 2008; 295(3): C779 - C790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. J. House, R. G. Ginnan, S. E. Armstrong, and H. A. Singer
Calcium/calmodulin-dependent protein kinase II-{delta} isoform regulation of vascular smooth muscle cell proliferation
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2276 - C2287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. R. Resnik, M. Keck, D. J. Sukovich, J. M. Herron, and D. N. Cornfield
Chronic intrauterine pulmonary hypertension increases capacitative calcium entry in fetal pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L953 - L959.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-Z. Xu, G. Boulay, R. Flemming, and D. J. Beech
E3-targeted anti-TRPC5 antibody inhibits store-operated calcium entry in freshly isolated pial arterioles
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2653 - H2659.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. R. Wamhoff, D. K. Bowles, and G. K. Owens
Excitation-Transcription Coupling in Arterial Smooth Muscle
Circ. Res., April 14, 2006; 98(7): 868 - 878.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. A. Barlow, P. Rose, R. A. Pulver-Kaste, and K. M. Lounsbury
Excitation-transcription coupling in smooth muscle
J. Physiol., January 1, 2006; 570(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Miguel-Velado, A. Moreno-Dominguez, O. Colinas, P. Cidad, M. Heras, M. T. Perez-Garcia, and J. R. Lopez-Lopez
Contribution of Kv Channels to Phenotypic Remodeling of Human Uterine Artery Smooth Muscle Cells
Circ. Res., December 9, 2005; 97(12): 1280 - 1287.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. K. Weir, J. Lopez-Barneo, K. J. Buckler, and S. L. Archer
Acute Oxygen-Sensing Mechanisms.
N. Engl. J. Med., November 10, 2005; 353(19): 2042 - 2055.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. B. Helli, E. Pertens, and L. J. Janssen
Cyclopiazonic acid activates a Ca2+-permeable, nonselective cation conductance in porcine and bovine tracheal smooth muscle
J Appl Physiol, November 1, 2005; 99(5): 1759 - 1768.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yang, S. Mergler, X. Sun, Z. Wang, L. Lu, J. A. Bonanno, U. Pleyer, and P. S. Reinach
TRPC4 Knockdown Suppresses Epidermal Growth Factor-induced Store-operated Channel Activation and Growth in Human Corneal Epithelial Cells
J. Biol. Chem., September 16, 2005; 280(37): 32230 - 32237.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. He, G. Yao, C. Savoia, and R. M. Touyz
Transient Receptor Potential Melastatin 7 Ion Channels Regulate Magnesium Homeostasis in Vascular Smooth Muscle Cells: Role of Angiotensin II
Circ. Res., February 4, 2005; 96(2): 207 - 215.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landsberg, J. W.
Right arrow Articles by Yuan, J. X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landsberg, J. W.
Right arrow Articles by Yuan, J. X.-J.